Arrowhead Pharma Q4 EPS $(3.01) Misses $(1.61) Estimate, Sales $37.794M Miss $55.838M Estimate

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(3.01) per share which missed the analyst consensus estimate of $(1.61) by 86.96 percent. This is a 1572.22 percent decrease over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $37.794 million which missed the analyst consensus estimate of $55.838 million by 32.32 percent. This is a 85.26 percent decrease over sales of $256.472 million the same period last year.